SCHEMBL19675236

SCHEMBL19675236

COc1cc2ccn(N)c(=O)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNF P01375 5/20 0.49
PSMB2 P49721 7/20 0.43
PSMB5 P28074 7/20 0.43
PSMB1 P20618 6/20 0.43
MPO P05164 1/20 0.42
XDH P47989 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
GAA P10253 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
MCL1 Q07820 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16328854 0.81 TNF (0.53) TNFPSMB2PSMB5PSMB1TDP1
SCHEMBL28039279 0.79 TNF (0.49) TNFPSMB2PSMB5PSMB1TDP1
SCHEMBL19675649 0.78 KDM4E (0.48) KDM4EALDH1A1MAPTHPGDGAA
SCHEMBL3949243 0.77 TNF (0.64) TNFPSMB2PSMB5PSMB1KDM4E
SCHEMBL28022549 0.72 MPO (0.39) MPOXDHKDM4EALDH1A1MAPT
SCHEMBL14149433 0.71 TNF (0.48) TNFPSMB2PSMB5PSMB1TDP1
SCHEMBL14106255 0.70 TNF (0.47) TNFPSMB2PSMB5PSMB1MAPT
SCHEMBL10651277 0.70 TNF (0.41) TNFPSMB2PSMB5PSMB1TDP1
SCHEMBL27751211 0.70 ALDH1A1 (0.50) KDM4EALDH1A1MAPTHPGDGAA
SCHEMBL6189209 0.69 TNF (0.52) TNFPSMB2PSMB5PSMB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed